Azz Inc, Wells Fargo, Tesla, Paychex Inc Equifax, Endocyte

It should be a fairly busy day on the corporate front, with plenty of newsflow after markets surged yesterday, despite the tragedy that unfolded in Las Vegas.

Azz Inc (NYSE:AZZ) will be in focus before the bell and shares dipped 1.29% to US$49.55 each after hours, having been higher earlier.

Wall Street expects the group to report quarterly earnings of $0.57 per share on revenues of $198.42mln. In the regular session, shares lost 3.19% to US$48.60.

It also promises to be a day of questions and answers for some in the USA. Hugely under-the -cosh credit score group Equifax (NYSE:EFX) will be on Capitol Hill on Tuesday for the first of three days of hearings over its massive security breach this year.

The event is made even more of a "white knuckle ride" as it comes the day after the group revealed the hack may have affected millions more customers than was stated before, bringing the total number to 145.5mln. Equifax shares added 3.17% on the day.

Banking group Wells Fargo (NYSE:WFC) is also in the frame and faces lawmakers on Tuesday. Shares shed 0.27% to US$53.32 on the day.

Chief executive  Tim Sloan reportedly plans to tell Congress that the bank failed to take decisive action to head off the scandal.

"We recognized too late the full scope and seriousness of the problems," Sloan will say in prepared testimony.

A powerful Democrat in Congress says regulators should consider shutting down Wells Fargo https://t.co/biSe1jXfi3 pic.twitter.com/WxvWdtvlyg

— CNN (@CNN) 2 October 2017

Elsewhere, Paychex Inc (NASDAQ:PAYX) shares added 0.23% after hours ahead of its results before the New York bell. The 'Street' expects it to have earned $0.6 per share on revenues of $816.30 million in its latest quarter.  In the regular session, shares added 3.29% toUS$61.78 each.

Shares of Endocyte Inc (NASDAQ:ECYT) surged over 49% to US$5.42 after hours after it reported the worldwide license of PSMA-617 from ABX GmbH.

The drug selectively delivers short-range beta-emitting radioactive isotope lutetium to tumor cells. Shares raced up over 56% on the day to US$5.68 each.

And California- based Tesla (NASDAQ:TSLA) shares saw its shares drop over 2% as it perhaps unsurprisingly in some eyes, the electric cars firm reported disappointing Model 3 delivery figures for the third quarter. On the day, Tesla shares accelerated 1.18% higher at US$345.56 each.